These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 36319976)

  • 41. Construction of a gene signature associated with anoikis to evaluate the prognosis and immune infiltration in patients with colorectal cancer.
    Wen H; Ni X; Qian S; Abdul S; Lv H; Chen Y
    Transl Cancer Res; 2024 Apr; 13(4):1904-1923. PubMed ID: 38737694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 46. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
    Cai Z; Zhou F
    Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of a novel Immune-Related prognostic model for patients with colorectal cancer based on 3 subtypes.
    Yang X; Wei Q
    Immunobiology; 2023 Mar; 228(2):152352. PubMed ID: 36827833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
    Chen S; Zhao E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
    Kim SK; Kim SY; Kim CW; Roh SA; Ha YJ; Lee JL; Heo H; Cho DH; Lee JS; Kim YS; Kim JC
    Exp Mol Med; 2019 Oct; 51(10):1-12. PubMed ID: 31578316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
    Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
    BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel acetylation-related gene signatures for predicting the prognosis of patients with colorectal cancer.
    Jing Z; Ziwang F; Yinhang W; Yani Z; Jian C; Jingwen W; Shuwen H
    Hum Cell; 2022 Jul; 35(4):1159-1173. PubMed ID: 35604486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosome secretion related gene signature predicts chemoresistance in patients with colorectal cancer.
    Ming L; Tang J; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Pathol Res Pract; 2024 May; 257():155313. PubMed ID: 38642509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Four‑Gene Biomarker for Tobacco Smoking-Induced Colorectal Cancer Progression.
    Jiang M; Zhang X; Huang H; Sun G; Huang Y; Chen Y
    Nicotine Tob Res; 2024 Sep; 26(10):1286-1295. PubMed ID: 38602278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
    Xiong J; Xiong S; Feng X; Zhang H; Su Q
    Biomed Res Int; 2022; 2022():2587120. PubMed ID: 35496037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
    Yuan J; Xie A; Cao Q; Li X; Chen J
    Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of 6 Hub Proteins and Protein Risk Signature of Colorectal Cancer.
    Yue T; Liu C; Zhu J; Huang Z; Guo S; Zhang Y; Xu H; Liu Y; Wang P; Chen S
    Biomed Res Int; 2020; 2020():6135060. PubMed ID: 33376727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.